Two examples of FDA-approved intracameral implants are Durysta (Allergan) and iDoseTR (Glaukos), both of which provide ...

NHS England has published updated medical retinal treatment pathway recommendations for wet age-related macular degeneration (wAMD), with pathways for diabetic macular oedema (DMO) and retinal vein ...

Kingston optician Eyecare Opticians (020 8549 0331) updates its eye exams with AI-enhanced OCT scanning that detects wet ...

Belite Bio has completed enrolment in the 24-month PHOENIX Phase III trial assessing the tolerability and safety of oral ...

A new study identifies how the molecule, called ApoM, can clear harmful cholesterol deposits linked to macular degeneration ...

Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...

The PHOENIX study is a 24-month, randomized, double-masked, placebo-controlled, multicenter, pivotal Phase 3 trial. The study is ongoing across sites in the United States, the United Kingdom, France, ...

Yesafili, a biosimilar to Eylea, received Health Canada's approval, marking the first such approval in Canada. Indicated for ...

In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS, highlights first-time ...

Career focused on driving business growth and developing an integrated commercial strategy to deliver results ...